Browsing Tag
UZEDY
4 posts
Can Elisabeth Svanberg help Medincell turn clinical progress into durable value?
Medincell wants pharmaceutical executive Elisabeth Svanberg to join its board and lead its remuneration and nomination committee. The proposal comes as the French biotechnology company moves from platform development towards recurring royalty growth and potential multi-product commercialisation.
Teva’s new bipolar breakthrough: FDA clears UZEDY as the first monthly long-acting risperidone
Teva’s UZEDY long-acting injectable gains FDA approval for bipolar I maintenance, reshaping psychiatric treatment and investor sentiment.
UZEDY wins FDA nod for Bipolar I maintenance therapy, boosting Teva and Medincell’s psychiatric drug portfolio
FDA expands UZEDY approval to Bipolar I maintenance therapy — explore how Teva and Medincell’s long-acting risperidone strategy is reshaping psychiatric care.
Teva Pharmaceuticals, MedinCell get UZEDY FDA approval for schizophrenia
Teva Pharmaceuticals and MedinCell have bagged approval for UZEDY (risperidone) extended-release injectable suspension from the US Food and…